PATENT CLAIM ANALYSIS

Application Number: 16008461
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "04400A"]

Abstract:
The invention relates to RNAi agents, e.g., double-stranded RNAi agents, targeting the Serpina1 gene, and methods of using such RNAi agents to inhibit expression of Serpina1 and methods of treating subjects having a Serpina1 associated disease, such as a liver disorder.

Claim (Index 6):
The dsRNA agent of  claim 1  or  4 , wherein the ligand is one or more GalNAc derivatives attached through a bivalent or trivalent branched linker.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 94.0
- Lexical Diversity: 1.56667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15399820', '14284745', '14947025', '14976261', '14699140']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8804037946063964
- 35 USC 102 Novelty (BERT): 0.7061339634817463
- Combined Prediction Score: 0.8629768114939315
- Mean Citation Score: 683.64558
- Max Citation Score: 773.87994
- Similarity Product: 732.4102973693097

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test